FDA Inspection 1021850 — Promethean LifeSciences, Inc.
The FDA completed an inspection of Promethean LifeSciences, Inc. on June 28, 2017 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 28, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Pittsburgh, PA (United States)